Basics Lyell Immunopharma, Inc. IPO Date: June 17, 2021 Sector: Healthcare Industry: Biotech Market Cap: $134.75M Activated in VL: True Average Daily Range Avg Daily Range: $0.19 | 4.23% Avg Daily Range (30 D): $0.44 | 4.31% Avg Daily Range (90 D): $0.31 | 5.34% Institutional Daily Volume Avg Daily Volume: .72M Avg Daily Volume (30 D): .07M Avg Daily Volume (90 D): .4M Trade Size Avg Trade Size (Sh.): 125 Avg Trade Size (Sh.) (30 D): 60 Avg Trade Size (Sh.) (90 D): 162 Institutional Trades Total Inst.Trades: 340 Avg Inst. Trade: $1.98M Avg Inst. Trade (30 D): $2.79M Avg Inst. Trade (90 D): $2.79M Avg Inst. Trade Volume: .02M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.31M Avg Closing Trade (30 D): $6.72M Avg Closing Trade (90 D): $6.72M Avg Closing Volume: 28.01K     News Jun 23, 2025 @ 9:00 PM Lyell Immunopharma to Participate in the H.C. Wain... Source: N/A May 1, 2025 @ 1:00 PM Lyell Immunopharma Announces Oral Presentation of ... Source: Lyell Immunopharma, Inc. Oct 24, 2024 @ 8:00 PM Lyell Immunopharma to Acquire ImmPACT Bio and Prio... Source: Globe Newswire Oct 4, 2024 @ 1:00 PM Lyell Immunopharma Announces the Acceptance Abstra... Source: N/A Jul 8, 2024 @ 5:02 PM Advanced Melanoma Clinical Trial Pipeline Analysis... Source: Delveinsight Financials   TTM Q1 2025 Q4 2024 Basic EPS $-1.25 $-.18 $-.72 Diluted EPS $-1.25 $-.18 $-.72 Revenue $ .07M $ .01M $ .01M Gross Profit $ $ $ Net Income / Loss $ -334.52M $ -52.2M $ -191.94M Operating Income / Loss $ -360.55M $ -57.37M $ -201.15M Cost of Revenue $ $ $ Net Cash Flow $ -3.92M $ 14.73M $ 6.7M PE Ratio     Splits Jun 02, 2025:   1:20